Leprosy in India: Experts fear a preventive antibiotic could lead to TB drug resistance

Rifampicin is being used as a preventive medication for leprosy but it is also used to treat tuberculosis, which affects lakhs of people in India every year.

Related Keywords

Mumbai ,Maharashtra ,India ,Hyderabad ,Andhra Pradesh ,Dadra ,Dadra And Nagar Haveli ,French Polynesia ,Uttar Pradesh ,Bengaluru ,Karnataka ,Bombay ,Rajit Yadav ,Bhushan Kumar ,Shafiqunissa Shaikh ,Girish Thakkar ,Anthony Samy ,Manoj Singh ,Ravita Yadav ,Pacific Ocean ,Research In Chandigarh ,Union Territory Of Dadra ,Institute Of Medical Education ,Union Ministry Of Health ,National Leprosy Eradication Programme ,Damien Foundation Of India ,Union Territory ,International Leprosy Congress ,Bombay Leprosy Project ,Nagar Haveli ,Union Ministry ,Family Welfare ,Biomed Central ,Alert India ,Tropical Diseases ,Post Graduate Institute ,Medical Education ,Damien Foundation ,Health ,Ifampicin ,Leprosy ,Leprosy In India ,Eprosy In India 2022 ,Ndia Drug Resistance ,Dr Tb India ,S Mdr Tb Curable In India ,Ndia Leprosy Statistics ,Ndia Leprosy Drug Resistance ,Eprosy Cases In India ,Ifampicin Dose In Leprosy ,Ifampicin For Leprosy ,